N@N

DEI, EFU, IPCI, PTX, ACTS, AVNR Are Seasonally Ripe To Go Down In the Next Five Weeks

October 31, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Douglas Emmett Inc (NYSE:DEI), ProShares UltraShort MSCI EAFE (NYSE:EFU), INTELLIPHARMACEUTICS INTERNA (NASDAQ:IPCI), Pernix Therapeutics Holdings Inc (AMEX:PTX), Actions Semiconductor Co Ltd (NASDAQ:ACTS), Avanir Pharmaceuticals Inc (NASDAQ:AVNR) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  DEI     Douglas Emmett Inc               -1.04%           66.67% (4 of 6)      Thursday, November 1st 2012
  EFU     ProShares UltraShort MSCI EAFE   -1.63%           100.00% (5 of 5)     Thursday, November 1st 2012
  IPCI    INTELLIPHARMACEUTICS INTERNA     -6.91%           75.00% (9 of 12)     Wednesday, November 7th 2012
  PTX     Pernix Therapeutics Holdings Inc  -13.05%          85.71% (12 of 14)    Friday, November 23rd 2012
  ACTS    Actions Semiconductor Co Ltd     -3.15%           100.00% (6 of 6)     Friday, November 9th 2012
  AVNR    Avanir Pharmaceuticals Inc       -7.00%           91.67% (11 of 12)    Wednesday, November 14th 2012

Douglas Emmett Inc (NYSE:DEI) - Douglas Emmett, Inc., a real estate investment trust, owns and operates office and multifamily properties in California and Hawaii. As of December 31, 2007, the companys office portfolio consisted of 48 properties and multifamily portfolio consisted of 9 properties. Its properties are located in Brentwood, Olympic Corridor, Century City, Beverly Hills, Santa Monica, Westwood, Sherman Oaks/Encino, Warner Center/Woodland Hills, and Burbank submarkets of Los Angeles County, California, as well as in Honolulu, Hawaii. The company is headquartered in Santa Monica, California..

ProShares UltraShort MSCI EAFE (NYSE:EFU) - UltraShort MSCI EAFE ProShares.

INTELLIPHARMACEUTICS INTERNA (NASDAQ:IPCI) - Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs. The companys patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of various existing and new pharmaceuticals. It has a pipeline of 15 products in various stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. The companys lead generic product under development includes generic Focalin XR (dexmethylphenidate hydrochloride), an extended-release capsule for the treatment of attention deficit hyperactivity disorder. Intellipharmaceutics has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. In addition, the company has two generic products filed with the FDA, including a generic of Effexor XR (venlafaxine hydrochloride) and Protonix (delayed release pantoprazole sodium). Its lead non-generic product under development is Rexista oxycodone, an abuse- and alcohol-resistant controlled-release oral oxycodone formulation for the relief of pain. The company also has products under late stage development, which consist of venlafaxine hydrochloride, an extended-release capsule for the treatment of symptoms of depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder; and carvedilol phosphate, an extended-release capsule for the treatment of hypertension and heart conditions. The company was formerly known as IntelliPharmaCeutics Ltd. and changed its name to Intellipharmaceutics International Inc. in October 2009. IntelliPharmaCeutics International Inc. was founded in 1998 and is based in Toronto, Canada..

Pernix Therapeutics Holdings Inc (AMEX:PTX) - Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, engages in the acquisition, development, marketing, and distribution of branded pharmaceutical products to meet unmet medical needs, primarily in pediatrics. It branded product families include CEDAX, Brovex, Aldex, Pediatex, ReZyst, QuinZyme, and Z-Cof. The company offers the ALDEX product line comprising ALDEX AN, ALDEX CT, ALDEX D, and ALDEX DM; and the BROVEX line, such as BROVEX PEB, BROVEX PEB DM, BROVEX PSB, BROVEX PSB DM, BROVEX PSE, and BROVEX PSE DM, which both are oral antihistamine/decongestant/antitussive (cough suppressant) combinations indicated for the treatment of allergies and symptoms of the common cold, as well as CEDAX, a prescription antibiotic used to treat mild to moderate infections of the throat, ear, and respiratory tract. Its Pediatex product line includes PEDIATEX TD, an oral antihistamine/decongestant combination indicated for the treatment of respiratory allergies; and Z-COF product line consists of Z-COF 8DM, an oral decongestant/expectorant/cough suppressant indicated for the treatment of allergies and symptoms of the common cold. The company's medical food product, REZYST IM, is a chewable tablet probiotic indicated to replace active cultures that are destroyed by diet and antibiotics and to reduce symptoms associated with irritable bowel syndrome and various gastrointestinal issues; and QUINZYME is a proprietary blend prescription supplement for the management of patients with depleted ubiquinone levels. It sells its products directly to drug wholesalers, who in turn distribute the products to retail drug stores, mass merchandisers, and grocery store pharmacies in the United States. The company was founded in 1999 and is based in Houston, Texas..

Actions Semiconductor Co Ltd (NASDAQ:ACTS) - Actions Semiconductor Co., Ltd. operates as a fabless semiconductor company in the Peoples Republic of China. The company designs, develops, and markets integrated platform solutions, including system-on-a-chips (SoCs), firmware, software development tools, and reference designs for the manufacturers of portable media players. Its SoCs are integrated circuits that incorporate digital signal processor, a micro controller unit, embedded memory, codec, a power management unit, and other components. The companys SoCs products also comprise on-chip memory, controllers for color liquid crystal display, and analog components, including digital-to-analog converters, phase lock loops, and USB transceivers. Actions Semiconductor Cos solution development kits include the embedded firmware code, software tools, and documentation to utilize its SoCs in portable media players. The companys firmware utilizes an embedded structure design with interface that allows customers to pick and choose functionalities and add new device drivers. Its manufacturing software tools also allow its customers in the mass production of products based on its turnkey process. The companys reference designs consist of detailed specifications of other required components and references, which allow customers to assemble a portable media player. Actions Semiconductor Co. also offers semiconductor product testing services. The company sells its integrated platform solutions directly, as well as through distributors to portable media player manufacturers, brand owners, and value-added distributors in China and internationally. Actions Semiconductor Co., Ltd. was founded in 2001 and is headquartered in Zhuhai, the Peoples Republic of China..

Avanir Pharmaceuticals Inc (NASDAQ:AVNR) - AVANIR Pharmaceuticals, Inc. focuses on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States and Canada. Its lead product candidate includes Zenviatm, which has completed three Phase III clinical trials for the treatment of pseudobulbar affect; and a Phase III trial for the treatment of patients with diabetic peripheral neuropathic pain. The company also offers Abreva, an over-the-counter product for the treatment of cold sores. AVANIR Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Aliso Viejo, California..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Contributing Sources

---